ID: ALA553995

Max Phase: Preclinical

Molecular Formula: C9H11ClFNO2

Molecular Weight: 183.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NC/C(=C/F)c1ccc(O)c(O)c1

Standard InChI:  InChI=1S/C9H10FNO2.ClH/c10-4-7(5-11)6-1-2-8(12)9(13)3-6;/h1-4,12-13H,5,11H2;1H/b7-4-;

Standard InChI Key:  RYUAAVLVGRUGKJ-ZULQGGHCSA-N

Associated Targets(non-human)

Monoamine oxidase 439 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 183.18Molecular Weight (Monoisotopic): 183.0696AlogP: 1.37#Rotatable Bonds: 2
Polar Surface Area: 66.48Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.42CX Basic pKa: 8.75CX LogP: 0.29CX LogD: -0.78
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.61Np Likeness Score: 0.71

References

1. McDonald IA, Lacoste JM, Bey P, Palfreyman MG, Zreika M..  (1985)  Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.,  28  (2): [PMID:3968682] [10.1021/jm00380a007]

Source